EP0944388 - INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 28.02.2003 Database last updated on 31.08.2024 | Most recent event Tooltip | 28.02.2003 | Application deemed to be withdrawn | published on 16.04.2003 [2003/16] | Applicant(s) | For all designated states Merck & Co., Inc. 126 East Lincoln Avenue Rahway, New Jersey 07065 / US | [N/P] |
Former [1999/39] | For all designated states MERCK & CO., INC. 126 East Lincoln Avenue Rahway, New Jersey 07065 / US | Inventor(s) | 01 /
ANTHONY, Neville, J. 126 East Lincoln Avenue Rahway, NJ 07065 / US | 02 /
DINSMORE, Christopher 126 East Lincoln Avenue Rahway, NJ 07065 / US | 03 /
GOMEZ, Robert, P. 126 East Lincoln Avenue Rahway, NJ 07065 / US | 04 /
HUTCHINSON, John, H. 126 East Lincoln Avenue Rahway, NJ 07065 / US | 05 /
WAI, John, S. 126 East Lincoln Avenue Rahway, NJ 07065 / US | 06 /
WILLIAMS, Theresa, M. 126 East Lincoln Avenue Rahway, NJ 07065 / US | 07 /
BELL, Ian, M. 126 East Lincoln Avenue Rahway, NJ 07065 / US | 08 /
EMBREY, Mark, W. 126 East Lincoln Avenue Rahway, NJ 07065 / US | 09 /
FISHER, Thorsten, E. 126 East Lincoln Avenue Rahway, NJ 07065 / US | [1999/39] | Representative(s) | Thompson, John, et al Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road Harlow, Essex CM20 2QR / GB | [N/P] |
Former [1999/39] | Thompson, John Dr., et al Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road Harlow, Essex CM20 2QR / GB | Application number, filing date | 97921256.0 | 27.03.1997 | [1999/39] | WO1997US06487 | Priority number, date | US19960014791P | 03.04.1996 Original published format: US 14791 P | GB19960009981 | 13.05.1996 Original published format: GB 9609981 | [1999/39] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO9738665 | Date: | 23.10.1997 | Language: | EN | [1997/45] | Type: | A2 Application without search report | No.: | EP0944388 | Date: | 29.09.1999 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.10.1997 takes the place of the publication of the European patent application. | [1999/39] | Search report(s) | International search report - published on: | US | 27.11.1997 | (Supplementary) European search report - dispatched on: | EP | 28.06.2001 | Classification | IPC: | A61K31/445, C07D401/04, C07D401/06, C07D401/12 | [1999/39] | CPC: |
C07D401/06 (EP);
A61P13/12 (EP);
A61P27/02 (EP);
A61P31/12 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
C07D211/62 (EP);
C07D401/12 (EP);
| Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE [1999/39] | Title | German: | HEMMERN VON FARNESYL PROTEIN TRANSFERASE | [1999/39] | English: | INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE | [1999/39] | French: | INHIBITEURS DE LA FARNESYL-PROTEINE TRANSFERASE | [1999/39] | Entry into regional phase | 03.11.1998 | National basic fee paid | 03.11.1998 | Search fee paid | 03.11.1998 | Designation fee(s) paid | 03.11.1998 | Examination fee paid | Examination procedure | 30.10.1997 | Request for preliminary examination filed International Preliminary Examining Authority: US | 03.11.1998 | Examination requested [1999/39] | 01.10.2002 | Application deemed to be withdrawn, date of legal effect [2003/16] | 05.11.2002 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2003/16] | Fees paid | Renewal fee | 31.03.1999 | Renewal fee patent year 03 | 31.03.2000 | Renewal fee patent year 04 | 02.04.2001 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 31.03.2002 | 06   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [PY]WO9610034 (MERCK & CO INC [US], et al) [PY] 1-25 * column W *; | [PY]WO9630343 (MERCK & CO INC [US], et al) [PY] 1-25 * column W *; | [PY]WO9609820 (MERCK & CO INC [US], et al) [PY] 1-25 * column W *; | [PY]WO9637204 (MERCK & CO INC [US], et al) [PY] 1-25 * column W *; | [A]WO9606609 (MERCK & CO INC [US], et al) [A] 1-25 * column W *; | [A]WO9500497 (MERCK & CO INC [US], et al) [A] 1-25 * column W *; | [A]EP0675112 (SQUIBB BRISTOL MYERS CO [US]) [A] 1-25 * column W *; | [A] - WILLIAMS,T. ET AL., "2-Substituted Piperazines as Constrained Amino Acids. Application to the Synthesis of Potent, Non Carboxylic Acid Inhibitors of Farnesyltransferase", J.MED.CHEM., WASHINGTON, (19960329), vol. 39, no. 7, pages 1345 - 1348, XP002169367 [A] 1-25 * column W * DOI: http://dx.doi.org/10.1021/jm9508090 | [A] - GRAHAM,S.L., "Inhibitors of protein farnesylation : a new approach to cancer chemotherapy", EXP.OPIN.THER.PATENTS, LONDON, (1995), vol. 5, no. 12, pages 1269 - 1285, XP001000610 [A] 1-25 * column W * DOI: http://dx.doi.org/10.1517/13543776.5.12.1269 | International search | [XE]WO9718813 (MERCK & CO INC [US], et al); | [XE]US5639775 (DURANT GRAHAM J [US], et al); | [X]US5478934 (YUAN JUN [US], et al) |